HK1146064A1 - 縮宮素類似物 - Google Patents

縮宮素類似物

Info

Publication number: HK1146064A1
Authority: HK; Hong Kong
Prior art keywords: oxytocin analogues; oxytocin; analogues
Prior art date: 2008-03-31

Application number

HK10112315.1A

Other languages

English (en)

Inventor

Sudar Algarsamy

Robert Galyean

Kazimierz Wisniewski

Claudio Schteingart

Original Assignee

Ferring Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-31

Filing date

2010-12-31

Publication date

2011-05-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39722695&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1146064(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-12-31 Application filed by Ferring Bv filed Critical Ferring Bv

2011-05-13 Publication of HK1146064A1 publication Critical patent/HK1146064A1/zh

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Genetics & Genomics (AREA)
Hematology (AREA)
Biophysics (AREA)
Psychiatry (AREA)
Immunology (AREA)
Pregnancy & Childbirth (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

HK10112315.1A 2008-03-31 2010-12-31 縮宮素類似物 HK1146064A1 (zh)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US4097308P	2008-03-31	2008-03-31
EP08251739		2008-05-19
PCT/IB2009/005351 WO2009122285A1 (en)	2008-03-31	2009-03-30	Oxitocin analogues

Publications (1)

Publication Number	Publication Date
HK1146064A1 true HK1146064A1 (zh)	2011-05-13

Family

ID=39722695

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK10112315.1A HK1146064A1 (zh)	2008-03-31	2010-12-31	縮宮素類似物

Country Status (21)

Country	Link
US (1)	US8673841B2 (zh)
EP (2)	EP2626364A1 (zh)
JP (1)	JP5539310B2 (zh)
KR (1)	KR101558404B1 (zh)
CN (1)	CN101983205B (zh)
AU (1)	AU2009233429B2 (zh)
BR (1)	BRPI0910345B1 (zh)
CA (1)	CA2718148C (zh)
DK (1)	DK2260053T3 (zh)
ES (1)	ES2488992T3 (zh)
HK (1)	HK1146064A1 (zh)
HR (1)	HRP20140716T1 (zh)
IL (1)	IL208039A (zh)
MX (1)	MX2010010743A (zh)
NZ (1)	NZ587817A (zh)
PL (1)	PL2260053T3 (zh)
PT (1)	PT2260053E (zh)
RU (1)	RU2496788C2 (zh)
SI (1)	SI2260053T1 (zh)
WO (1)	WO2009122285A1 (zh)
ZA (1)	ZA201006733B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011147889A1 (en)	2010-05-25	2011-12-01	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient
JO3400B1 (ar)	2010-09-30	2019-10-20	Ferring Bv	مركب صيدلاني من كاربيتوسين
CA2895150C (en)	2012-12-21	2019-11-26	F. Hoffmann-La Roche Ag	Peptides as oxytocin agonists
EA030091B1 (ru)	2014-06-03	2018-06-29	Ф. Хоффманн-Ля Рош Аг	Пептиды, выполняющие роль агонистов окситоцина
CR20160562A (es) *	2014-06-06	2017-01-06	Hoffmann La Roche	Péptidos como agonistas de la oxitocina
US10588980B2 (en)	2014-06-23	2020-03-17	Novartis Ag	Fatty acids and their use in conjugation to biomolecules
WO2016044131A1 (en)	2014-09-19	2016-03-24	Ferring B.V.	Method of treating prader-willi syndrome
CN106084015B (zh) *	2016-08-25	2020-01-31	成都圣诺生物制药有限公司	一种合成卡贝缩宫素的方法
US20190135859A1 (en)	2017-08-11	2019-05-09	Ferring B.V.	Method of manufacturing a pharmaceutical composition
BR112020001832A2 (pt)	2017-08-11	2020-07-28	Ferring B.V.	método de produção de uma composição farmacêuti-ca
CN107628975B (zh) *	2017-09-17	2019-10-29	贵州医科大学	赖氨酸衍生物类组蛋白去乙酰化酶抑制剂及其合成和应用
AU2019345313A1 (en)	2018-09-20	2021-03-18	Levo Therapeutics, Inc.	Carbetocin drug product and process for preparing same
AU2019345166B2 (en)	2018-09-20	2021-09-02	Levo Therapeutics, Inc.	Stable intranasal formulations of carbetocin
WO2020137880A1 (ja) *	2018-12-27	2020-07-02	国立大学法人北海道大学	オキシトシン誘導体及びその使用
EP4054521A1 (en)	2019-11-04	2022-09-14	Ferring B.V.	Intranasal administration of merotocin for improving lactation
US20230265124A1 (en) *	2020-07-27	2023-08-24	Az. Bd. of Reg. on Behalf of the Univ. of Arizona	Oxytocin analogues and methods for using the same
CA3214303A1 (en)	2021-03-26	2022-09-29	Ot4B	Treatment of dysphagia
WO2024044633A2 (en) *	2022-08-23	2024-02-29	Seattle Children's Hospital (D/B/A Seattle Children's Research Institute)	Oxytocin derivatives and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9604341D0 (sv) *	1996-11-26	1996-11-26	Ferring Bv	Hepta-peptide oxytocin analogue
DE60309847T2 (de)	2002-02-27	2007-10-18	Ferring B.V.	Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga

2009
- 2009-03-30 NZ NZ587817A patent/NZ587817A/en unknown
- 2009-03-30 KR KR1020107024207A patent/KR101558404B1/ko active IP Right Grant
- 2009-03-30 BR BRPI0910345-7A patent/BRPI0910345B1/pt active IP Right Grant
- 2009-03-30 CA CA2718148A patent/CA2718148C/en active Active
- 2009-03-30 EP EP13156710.9A patent/EP2626364A1/en not_active Withdrawn
- 2009-03-30 EP EP09727031.8A patent/EP2260053B1/en active Active
- 2009-03-30 PT PT97270318T patent/PT2260053E/pt unknown
- 2009-03-30 AU AU2009233429A patent/AU2009233429B2/en active Active
- 2009-03-30 RU RU2010139634/04A patent/RU2496788C2/ru active
- 2009-03-30 PL PL09727031T patent/PL2260053T3/pl unknown
- 2009-03-30 DK DK09727031.8T patent/DK2260053T3/da active
- 2009-03-30 WO PCT/IB2009/005351 patent/WO2009122285A1/en active Application Filing
- 2009-03-30 MX MX2010010743A patent/MX2010010743A/es active IP Right Grant
- 2009-03-30 SI SI200930966T patent/SI2260053T1/sl unknown
- 2009-03-30 JP JP2011502454A patent/JP5539310B2/ja active Active
- 2009-03-30 ES ES09727031.8T patent/ES2488992T3/es active Active
- 2009-03-30 US US12/933,858 patent/US8673841B2/en active Active
- 2009-03-30 CN CN200980111919.5A patent/CN101983205B/zh active Active
2010
- 2010-09-07 IL IL208039A patent/IL208039A/en active IP Right Grant
- 2010-09-20 ZA ZA2010/06733A patent/ZA201006733B/en unknown
- 2010-12-31 HK HK10112315.1A patent/HK1146064A1/zh unknown
2014
- 2014-07-25 HR HRP20140716AT patent/HRP20140716T1/hr unknown

Also Published As

Publication number	Publication date
EP2260053B1 (en)	2014-05-14
EP2626364A1 (en)	2013-08-14
PL2260053T3 (pl)	2014-11-28
JP5539310B2 (ja)	2014-07-02
KR20110005705A (ko)	2011-01-18
BRPI0910345B1 (pt)	2021-08-17
ZA201006733B (en)	2011-06-29
IL208039A (en)	2016-03-31
US8673841B2 (en)	2014-03-18
RU2010139634A (ru)	2012-05-10
SI2260053T1 (sl)	2014-08-29
WO2009122285A1 (en)	2009-10-08
RU2496788C2 (ru)	2013-10-27
KR101558404B1 (ko)	2015-10-08
CN101983205B (zh)	2015-08-19
AU2009233429A1 (en)	2009-10-08
MX2010010743A (es)	2010-11-04
CN101983205A (zh)	2011-03-02
AU2009233429B2 (en)	2014-02-13
CA2718148A1 (en)	2009-10-08
EP2260053A1 (en)	2010-12-15
PT2260053E (pt)	2014-08-29
JP2011516460A (ja)	2011-05-26
NZ587817A (en)	2012-05-25
CA2718148C (en)	2017-11-07
BRPI0910345A2 (pt)	2015-10-06
HRP20140716T1 (hr)	2014-08-29
WO2009122285A8 (en)	2009-12-10
DK2260053T3 (da)	2014-06-23
ES2488992T3 (es)	2014-09-01
IL208039A0 (en)	2010-12-30
US20110044905A1 (en)	2011-02-24

Legal Events

Date	Code	Title	Description
2015-08-14	CHRG	Changes in the register	Free format text: CORRECTION OF THE NAME OF THE INVENTOR FROM ALGARSAMY, SUDAR TO ALAGARSAMY, SUDARKODI

Publication	Publication Date	Title
HK1146064A1 (zh)	2011-05-13	縮宮素類似物
HK1203531A1 (zh)	2015-10-30	胰高血糖素類似物
ZA201104592B (en)	2013-11-27	Glucagon analogues
ZA201104593B (en)	2015-01-28	Glucagon analogues
ZA201104591B (en)	2014-11-26	Glucagon analogues
EP2246950A4 (en)	2012-10-31	EYELET
EP2278675A4 (en)	2012-04-04	SPOUT
EP2276132A4 (en)	2012-07-11	SPOUT
EP2284970A4 (en)	2012-07-11	SPOUT
EP2276134A4 (en)	2012-04-04	GROMMET
EP2253381A4 (en)	2014-02-26	AIR PROCESSOR
EP2248703A4 (en)	2012-12-26	PASS CABLE
GB2479441B (en)	2017-08-23	Coelenterazine analogues
GB2488742B (en)	2014-09-17	Jigsaw
EP2276133A4 (en)	2012-03-28	SPOUT
TWI368572B (en)	2012-07-21	Printing-table arrangement
EP2392824A4 (en)	2016-03-23	AIR PUMP
EP2285379A4 (en)	2011-11-02	ANALOGUES OF 1-METHYLNICOTINAMIDE
EP2392821A4 (en)	2016-03-23	AIR PUMP
GB0820166D0 (en)	2008-12-10	Former
HK1156630A1 (en)	2012-06-15	Schweinfurthin analogues schweinfurthin
EP2392822A4 (en)	2016-05-11	AIR PUMP
GB2463042B (en)	2012-07-04	Stabalizer arrangement
GB0805372D0 (en)	2008-04-30	Pathfinder
GB0805969D0 (en)	2008-05-07	Clevertee pro